Delivery Order SPE2DB22D2206-SPE2DB24FGP53
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rifampin 300 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $36,030.72 and a performance period ending on April 24, 2025. The contract is not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.31 firm fixed-price delivery order contract is for the supply of RIFAMPIN 300 MG CAPSULE 30S, a critical pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,937.51 firm fixed price delivery order covers the supply of 4,559,463,209 units of Rifampin 300 mg capsules. The contract has an ultimate completion date of December 29, 2022 and was awarded on December 28, 2022. This award is associated with AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4,563,216 Rifampin 300 mg capsules. The contract has a ceiling value of $59,634.48 and a period of performance ending on January 3, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this award, which is part of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Rifampin 300 mg capsules, a specialty pharmaceutical product, with a total ceiling value of $5,130.79 and a performance period through March 29, 2024. This award is a task order under a larger indefinite delivery contract...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,563,956,698 units of Rifampin 300 mg capsules. The contract, valued at $1,203.66, has an ultimate completion date of March 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,648.47, is for the delivery of 4,567,529,290 units of Rifampin 300mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,265.78 for the supply of 60 capsules of Rifampin 300 mg. The contract has a completion date of May 30, 2024 and is a Firm Fixed Price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
- This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $2,814.25, is a Firm Fixed Price Delivery Order for the supply of Rifampin 300 mg capsules. The contract has an ultimate completion date of December 20, 2022 and was awarded on December 19, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,782.72 firm fixed-price delivery order is for the supply of 300 mg Rifampin capsules. The contract has an ultimate completion date of February 7, 2025 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGP53Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, a delivery order with a firm fixed price, has a ceiling value of $2,042.53 and a completion date of April 11, 2024. The contract is for the provision of Rifampin 300 mg capsules, a specialty pharmaceutical product. Amerisourcebergen Drug Corp serves as the prime contractor, with no set-aside designation indicated. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and a performance period through December 31, 2025, which enables Amerisourcebergen to deliver a comprehensive range of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 4/10/24 |